 Myriad Genetics, Inc. NASDAQ:MYGN Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matthew Scalo - SVP, Investor Relations Paul Diaz - CEO, President Director Nicole Lambert - COO Bryan Riggsbee - EVP, CFO Treasurer Conference Call Participants Daniel Brennan - Life Science Diagnostic Tools Matthew Sykes - Goldman Sachs Jack Meehan - Nephron Research Mason Carrico - Stephens Incorporated Brandon Couillard - Jefferies Julia Kim - JPMorgan Puneet Souda - SVB Securities Operator Greetings, and welcome to the Myriad Genetics Third Quarter 2022 Financial Earnings Conference Call. Operator Instructions. 